Sinopharm
1099.HK
#1870
Rank
NZ$15.23 B
Marketcap
$4.88
Share price
-0.23%
Change (1 day)
26.97%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total debt

Total debt on the balance sheet as of December 2023 : NZ$18.45 Billion

According to Sinopharm's latest financial reports the company's total debt is NZ$18.45 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sinopharm - Total debt on balance sheet (from 2008 to 2023)

Total debt by year

Year Total debt Change
2022-12-31NZ$21.58 B37.4%
2021-12-31NZ$15.70 B7.87%
2020-12-31NZ$14.56 B24.24%
2019-12-31NZ$11.72 B-1.89%
2018-12-31NZ$11.94 B48.19%
2017-12-31NZ$8.06 B15.74%
2016-12-31NZ$6.96 B6.66%
2015-12-31NZ$6.52 B7.54%
2014-12-31NZ$6.07 B20.1%
2013-12-31NZ$5.05 B60.65%
2012-12-31NZ$3.14 B11.45%
2011-12-31NZ$2.82 B319.29%
2010-12-31NZ$0.67 B94.37%
2009-12-31NZ$0.34 B-16.18%
2008-12-31NZ$0.41 B-0.43%
2007-12-31NZ$0.41 B21.29%
2006-12-31NZ$0.34 B